CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.

In conclusion, Ab-PEG-Bi2Se3 may serve as an efficient PTT platform in combination with macrophage-mediated immunotherapy to improve antitumor efficacy.
PMID: 31606701 [PubMed - as supplied by publisher]

Source: Colloids and Surfaces - October 2, 2019 Category: Biotechnology Authors: Guo Z, Liu Y, Zhou H, Zheng K, Wang D, Jia M, Xu P, Ma K, Cui C, Wang L Tags: Colloids Surf B Biointerfaces Source Type: research